Drug Resistance, Bacterial
"Drug Resistance, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
MeSH Number(s)
G06.099.225
G06.225.347
G07.690.320.269.347
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Bacterial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Bacterial".
This graph shows the total number of publications written about "Drug Resistance, Bacterial" by people in Harvard Catalyst Profiles by year, and whether "Drug Resistance, Bacterial" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 2 | 3 | 5 |
| 2002 | 14 | 12 | 26 |
| 2003 | 7 | 9 | 16 |
| 2004 | 17 | 14 | 31 |
| 2005 | 15 | 19 | 34 |
| 2006 | 11 | 13 | 24 |
| 2007 | 14 | 12 | 26 |
| 2008 | 18 | 12 | 30 |
| 2009 | 17 | 7 | 24 |
| 2010 | 15 | 14 | 29 |
| 2011 | 12 | 22 | 34 |
| 2012 | 19 | 13 | 32 |
| 2013 | 11 | 16 | 27 |
| 2014 | 16 | 15 | 31 |
| 2015 | 20 | 22 | 42 |
| 2016 | 31 | 26 | 57 |
| 2017 | 28 | 24 | 52 |
| 2018 | 35 | 20 | 55 |
| 2019 | 40 | 19 | 59 |
| 2020 | 27 | 27 | 54 |
| 2021 | 23 | 22 | 45 |
| 2022 | 11 | 9 | 20 |
| 2023 | 6 | 24 | 30 |
| 2024 | 0 | 6 | 6 |
Below are the most recent publications written about "Drug Resistance, Bacterial" by people in Profiles.
-
Global diversity of enterococci and description of 18 previously unknown species. Proc Natl Acad Sci U S A. 2024 Mar 05; 121(10):e2310852121.
-
Prevalence, risk factors, and antimicrobial resistance of endemic healthcare-associated infections in Africa: a systematic review and meta-analysis. BMC Infect Dis. 2024 Feb 02; 24(1):158.
-
Characterization of the resistome and predominant genetic lineages of Gram-positive bacteria causing keratitis. Antimicrob Agents Chemother. 2024 Mar 06; 68(3):e0124723.
-
Antimicrobial resistance of Streptococcus pneumoniae from invasive pneumococcal diseases in Latin American countries: a systematic review and meta-analysis. Front Public Health. 2024; 12:1337276.
-
Streptococcus pneumoniae favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones. mBio. 2024 Feb 14; 15(2):e0282823.
-
The Impact of Rapid Drug Susceptibility Tests on Gonorrhea Burden and the Life Span of Antibiotic Treatments: A Modeling Study Among Men Who Have Sex With Men in the United States. Am J Epidemiol. 2024 Jan 08; 193(1):17-25.
-
CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual). Clin Infect Dis. 2023 12 20; 77(Suppl 7):S536-S542.
-
Effective Stakeholder Engagement for Collation, Analysis and Expansion of Antimicrobial Resistance (AMR) Data: A CAPTURA Experience. Clin Infect Dis. 2023 12 20; 77(Suppl 7):S519-S527.
-
Antimicrobial Resistance Surveillance Methods in Bangladesh: Present and Way Forward. Clin Infect Dis. 2023 12 20; 77(Suppl 7):S549-S559.
-
Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA). Clin Infect Dis. 2023 12 20; 77(Suppl 7):S500-S506.